2022年至2024年，三英精密营业收入分别为1.28亿元、1.8亿元、2.35亿元，归母净利润分别为295.84万元、1425.23万元、2724.77万元。 2025年前三季度，三英精密营业收入为2.11亿元，同比增长33.51%，归母净利润为3046.03万元，同比增长98.82%。 三英精密成立于2013年11月，注册资本3845.34万元，法定代表人为须颖，是一家专业从事X射线CT检测装备研发和制造的国家高新技术企业，拥有自主核 心技术，现已发展为国内X射线CT产品种类齐全的解决方案提供商。 公司控股股东为须颖。须颖直接持股17.12%，须颖控制的英池（天津）企业管理中心（有限合伙）、博维（天津）企业管理中心（有限合伙）分别持有公 司7.54%、4.93%股权，须颖直接和间接控制公司29.59%的表决权。 刘颖与控股股东须颖为夫妻关系，二人共同为公司实际控制人，实际控制人对公司的直接持股比例为18.57%，间接持股比例为13.53%。 另外，比亚迪、深创投、保腾创投参股。 | 辅导对象 | 天津三英精密仪器股份有限公司 | | | | --- | --- | --- | --- | | 成立日期 | ...

Core Viewpoint - SanYing Precision has reported a high growth in net profit that significantly outpaces revenue growth, driven by increased order acceptance and excellent cost control, with new industrial bases and CNAS certification providing dual momentum for future growth [1][2]. Financial Performance - For the first three quarters of 2025, SanYing Precision achieved operating revenue of 211 million yuan, representing a year-on-year increase of 33.51% [4]. - The net profit attributable to shareholders reached 30 million yuan, showing a substantial year-on-year growth of 98.82%, nearly doubling [4]. - The basic earnings per share also increased by 98.82% to 0.7921 yuan [4]. - In Q3 2025, the company recorded a single-quarter operating revenue of 83 million yuan, with a year-on-year growth of 48.45% [4]. - The net profit for Q3 was 17 million yuan, reflecting a significant year-on-year increase of 120.02%, surpassing the total profit of the first half of the year [4]. Growth Drivers - The increase in operating revenue is primarily attributed to a significant rise in the sales orders of equipment that were completed and accepted by customers during the reporting period [5]. - The net profit growth outpaced revenue growth due to effective control over period expenses, which grew at a rate much lower than that of operating revenue [5]. Asset and Equity Position - As of September 30, 2025, SanYing Precision's total assets reached 690 million yuan, a growth of 42.03% compared to the end of the previous year [6]. - The net assets attributable to shareholders amounted to 361 million yuan, reflecting a year-on-year increase of 9.23% [6]. Strategic Development - SanYing Precision has made significant strategic investments in technology research and development, capacity expansion, and quality system construction [7]. - The company announced plans to invest no more than 160 million yuan in establishing a new R&D and industrialization base for 3D imaging detection equipment [8]. - This project, which commenced on April 9 in Dongli District, Tianjin, covers an area of 38.2 acres with a planned total construction area of approximately 30,000 square meters, aiming to achieve an annual production capacity of 600 units of industrial CT equipment [9]. Certification and Recognition - Recently, SanYing Precision's testing center successfully passed the CNAS certification, receiving the CNAS laboratory accreditation certificate [10][11]. - This certification signifies that the company's testing capabilities and management standards meet internationally recognized benchmarks, enhancing its authority and credibility in the non-destructive testing field [12].

证券之星消息，根据天眼查APP于10月8日公布的信息整理，天津三英精密仪器股份有限公司定向增发 融资，融资额1.10亿人民币，参与投资的机构包括国家制造业转型升级基金，深创投，顺为资本。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 天津三英精密仪器股份有限公司（股票代码：839222）成立于2013年，是一家专业从事X射线CT检测装 备研发和制造的国家高新技术企业，拥有自主核心技术，现已发展为国内X射线CT产品种类齐全的解决 方案提供商。三英精密承担科技部国家重大仪器设备开发专项、863计划项目、国家科技支撑计划项目 等多项国家科研项目，荣获天津市专利试点单位和天津市战略性新兴产业领军企业。 数据来源：天眼查APP | 公布日 | 投资方 | 交易全额 | 融资轮次 | | --- | --- | --- | --- | | | 国家制造业转型升级基金 | | | | 2025-10-08 | 深创投 | 1.10亿人民币 | 定向增发 | | | 顺为资本 | | | | 2023-11-06 | 深创投 开源证券 | 1.3 ...